Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age.
Oral oncology
View this publicationOral oncology
View this publicationDer Nervenarzt
View this publicationThe American journal of tropical medicine and hygiene
View this publicationCardiovascular research
View this publicationCurrent opinion in cardiology
View this publicationNature reviews. Drug discovery
View this publicationJournal of thrombosis and thrombolysis
View this publicationAmerican journal of human genetics
View this publicationCells
View this publicationTherapeutic advances in hematology
View this publication